India’s Cardiovascular Monitoring Devices Market Set for Solid Growth

Cardiac disease is not just an American health issue. It’s become a worldwide problem.

In India, for example, crude cardiovascular mortality is expected to rise 91.2% between 2025 and 2050 despite a 23.0% decrease in the age-standardized cardiovascular mortality rate, according to research. Consequently, driven by rising cardiac disease, prevalence, growing demand for continuous monitoring, and the rapid adoption of artificial intelligence (AI)-enabled wearable technologies, the cardiovascular monitoring devices market in India is expected to reach $153 million in 2036, forecasts GlobalData.

The company’s report, “Cardiovascular Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036,” reveals that India is one of the fastest-growing markets in the Asia-Pacific (APAC) region, representing 7% of the area last year.

“The rising burden of cardiovascular diseases and the shift toward connected, AI-driven monitoring platforms are prompting sustained investment in India’s cardiac diagnostics space,” GlobalData Medial Devices Analyst Sarvesh Kumar said. “Manufacturers are now prioritizing smart, patient-friendly devices that deliver higher clinical accuracy and meet the needs of both hospitals and home-care settings.”

The launch of vCardio, an AI-powered wearable cardiac monitor developed by Chennai-based vTitan, exemplifies this trend. Designed as a single-lead, lightweight device, vCardio enables continuous ECG capture and uses cloud-integrated AI algorithms to detect and classify more than 20 clinically relevant arrhythmias. Such innovations are enhancing diagnostic precision, streamlining workflows, and expanding opportunities for remote monitoring and long-term cardiac risk management.

However, the market continues to face challenges, including limited access to trained cardiac specialists in rural regions, inconsistent reimbursement coverage for advanced monitoring devices, and high deployment costs in smaller healthcare facilities.

“Growth opportunities may be unlocked through better reimbursement support, increased participation from private diagnostic networks, and workforce development programs that strengthen cardiac screening capabilities across India,” Kumar stated. “These improvements could allow a wider patient population to benefit from advanced cardiovascular monitoring technologies, supporting steady market expansion through 2036.”

GlobalData aims to help clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology, and professional services sectors.